| Biological Information | |
|---|---|
| Background Information: | AMPK (α2, β1, γ1) is a metabolic master switch, activated by exercise and muscle contraction. AMPK phosphorylate key target proteins that control glucose uptake, oxidation of fatty acids, cholesterol synthesis, lipogenesis, triglyceride synthesis, adipocyte lipolysis, glycolysis and nitric oxide synthesis.
GenBank NM_006252 / GenBank NM_006253 / GenBank NM_002733 |
| Target Class: | Kinase |
| Accession Number: | NM_006252; NM_006253; NM_002733 |
| Target Name: | AMPK (α2, β1, γ1) |
| Target Aliases: | PRKAB1PRKAG1PRKAA2 |
| Target Species: | Human |
| Usage | |
| Product Type: | Enzymes |
| Application: | Drug Discovery & Development |
| Storage Conditions: | 6 months at -70°C |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
AMPK (alpha2, beta1, gamma1), active
Recombinant, human AMPK (α2, β1, γ1) holoenzyme, comprised of full length N-terminal 6His-tagged AMPKα2, full length untagged AMPKβ1 and full length untagged AMPKγ1.
Datasheets
14-902x Datasheet
View Document